CLINICO-EPIDEMIOLOGICAL STUDY OF ENDOMETRIAL HYPERPLASIA – A RISK FACTOR FOR THE DEVELOPMENT OF ENDOMETRIAL CARCINOMA?

Authors

  • A. CARAULEANU University of Medicine and Pharmacy “Grigore T. Popa” - Iasi
  • Ivona ANGHELACHE LUPASCU “Cuza Vodă” Obstetrics and Gynecology Clinical Hospital of Iaşi
  • Daniela Mihaela CARAULEANU “Cuza Vodă” Obstetrics and Gynecology Clinical Hospital of Iaşi
  • R. SOCOLOV University of Medicine and Pharmacy “Grigore T. Popa” - Iasi
  • Demetra SOCOLOV University of Medicine and Pharmacy “Grigore T. Popa” - Iasi

Abstract

Aim: Metaplasia is defined as a transformation of an adult epithelial or conjunctive cellular type into another adult cellular type. Endometrial hyperplasia and particularly complex atypical hyperplasia exposes to a high risk of development of the endometrial carcinoma, being considered a lesion precursory to the same. Endometrial hyperplasias are risk factors for the development of endometrial carcinoma and their prophylaxis implies their accurate diagnosis, taking into account that the adenocarcinomas diagnosed in an advanced stage, whose therapeutic context differs from the early stages, have a much lower chance of survival. Material and methods: Our study aimed at highlighting objective criteria in establishing the morphological diagnosis and in evaluating the prognostic elements. The studied batch included 875 patients with endometrial hyperplasia and 263 patients with endometrial adenocarcinoma, who were admitted between 2003 and 2007, and the histopathologic diagnosis was obtained by processing the hysterectomy pieces. The presence of this tumour was at its highest level half-way through the study, which was in 2005. Results: According to the study, there was a higher proportion of patients with endometrial carcinoma from the urban environment (58.2%) than the ones from the rural environment (only 41.8%). Depending on their age, most cases of endometrial adenocarcinoma were diagnosed in 53-year old patients, with an average age of 58.94 years. Our study, made of the two batches of endometrial adenocarcinomas, shows that between the endometrial and non-endometrial adenocarcinoma there are significant differences related to the patients’ age, the morphological aspect of the carcinoma, the architectural degree, the nuclear degree of tumours and the invasion in the myometrium. Conclusions: Our study proves that endometrial hyperplasia is a frequent diagnosis in peri- and postmenopausal patients and is frequently identified following investigations for an abnormal uterine bleeding. The age of patients with endometrial carcinoma is an important prognostic factor independent of other parameters. The difference between complex hyperplasia with no atypias and complex hyperplasia with atypias is important, because atypical complex hyperplasia is considered the precursor of endometrial adenocarcinoma.

Author Biographies

  • A. CARAULEANU, University of Medicine and Pharmacy “Grigore T. Popa” - Iasi

    Department of Mother and Child Medicine

  • Ivona ANGHELACHE LUPASCU, “Cuza Vodă” Obstetrics and Gynecology Clinical Hospital of Iaşi

    1s Clinic of Obstetrics and Gynecology

  • Daniela Mihaela CARAULEANU, “Cuza Vodă” Obstetrics and Gynecology Clinical Hospital of Iaşi

    1s Clinic of Obstetrics and Gynecology

  • R. SOCOLOV, University of Medicine and Pharmacy “Grigore T. Popa” - Iasi

    Department of Mother and Child Medicine

  • Demetra SOCOLOV, University of Medicine and Pharmacy “Grigore T. Popa” - Iasi

    Department of Mother and Child Medicine

References

1. Abeler VM, Kjorstad KE. Endometrial Squamous Cell Carcinoma: Report of Three Cases and Review of the Literature. Gynecol Oncol 1990; 36: 321-326.
2. Abeler VM. Aggressive Forms of Endometrial Carcinoma. Pathology of Endometrium. Short Courses. Pathol 1999; 417-418.
3. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial Cancer. Lancet 2005; 366: 491-505.
4. Baak JPA, Wisse-Brekelmans ECM, Fleege JC et al. Assessment of Risk of Endometrial Cancer in Hyperplasia, by Means of Morphologic and Morphometric Features. Pathol Res Pract 1992; 188: 856-859.
5. Bilgin T, Ozuysal S, Ozan H et al. Coexisting Endometrial Cancer in Patients with a Preoperative Diagnosis of Atypical Endometrial Hyperplasia. J Obstet Gynecol Res 2004; 30: 205
6. Brown J, Thumber S, Hricak H. MR Imaging of the Uterus: Low-Signal Intensity Abnormalities of the Endometrium and Endometrial Cavity. Magn Reson Imaging 1990; 8(3): 309-13.
7. Burke TW, Tortolero-Luna G, Malpica A. Endometrial Hyperplasia and Endometrial Cancer. Obstet Gynecol Clin North America 1996; 23: 411-456.
8. Clark TJ, Neelakantan D, Gupta JK. The Management of Endometrial Hyperplasia: An Evaluation of Current Practice. Eur J Obstet Gynecol Reprod Biol 2006; 125: 259-264.
9. Dumitru Daniela-Mihaela, Onofriescu M., Cărăuleanu A., Rădulescu Doiniţa. The Endovaginal Ultra-sound Findings of a Thin and Regular Endometrum Is Uncommon in Endometrial Cancer. Rev Med Chir Soc Med Nat Iasi 2009; 113(1): 132-135.
10. Horn LC, Schnurrbusch U, Bilek K, et al. Risk of Progression in Complex and Atypical Endometrial Hyperplasia: Clinicopathologic Analysis in Cases With and Without Progestogen Treatment. Int J Gynecol Cancer 2004; 14: 348-53.
11. Mincă DG, Marcu MG. Sănătate publică şi management sanitar, note de curs pentru învăţământul postuniversitar, ed. a II-a revizuită, Ed. Universitară „Carol Davila”, Bucharest, 2005.
12. Moss A, Gamsu G, Genant H. Computed Tomography of the Body with Magnetic Resonance Imaging Vol. Three: Abdomen and Pelvis. WB Saunders Co Philadelphia, 1992.
13. Pangal Alexandra, Costăchescu Gh., Aldea Marie Jeanne. Metodologia diagnosticului hiperplaziilor endometriale. Examen clinic, paraclinic şi management. Rev Med Chir Soc Med Nat Iasi 2010; 114(2): 445-449.
14. Pricop M. Oncologie ginecologică clinică, Polirom 2000: 159-160
15. Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2005. Cancer J Clin 2005; 55(1): 31-44.

Additional Files

Published

2015-03-31